Multiple Sclerosis News Today2h
In a life with multiple sclerosis, how do you motivate yourself?
Columnist Ben Hofmeister explains a handy acronym that's helped him and can help you motivate yourself with MS.
The American Journal of Managed Care4h
Real-World Discontinuations of Ocrelizumab in MS Comparable to Pivotal Trials
Data from a systematic review of 30 real-world studies show comparable discontinuation rates of ocrelizumab to those in ...
Multiple Sclerosis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Epidemiology, Therapies and Companies by DelveInsight
Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Genzyme, ImStem Biotechnology, Rho, Inc., ...
Science Daily3d
Multiple Sclerosis News
2024 — Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical trials ...
The American Journal of Managed Care23h
Subcutaneous Ocrelizumab Well Tolerated in Patients With MS
Subcutaneous ocrelizumab (SC OCR) was found to be safe for patients with relapsing and primary progressive multiple sclerosis ...
Hosted on MSN5d
Reproductive Health in Multiple Sclerosis
Many people living with the degenerative neurological disease multiple sclerosis (MS) are premenopausal women. This means ...
Science Daily17h
Multiple Sclerosis Research News
2024 — Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical trials ...